Curcumin counteracts loss of force and atrophy of hindlimb unloaded rat soleus by hampering neuronal nitric oxide synthase untethering from sarcolemma.
Antioxidant administration aimed to antagonize the development and progression of disuse muscle atrophy provided controversial results. Here we investigated the effects of curcumin, a vegetal polyphenol with pleiotropic biological activity, because of its ability to upregulate glucose-regulated protein 94 kDa (Grp94) expression in myogenic cells. Grp94 is a sarco-endoplasmic reticulum chaperone, the levels of which decrease significantly in unloaded muscle. Rats were injected intraperitoneally with curcumin and soleus muscle was analysed after 7 days of hindlimb unloading or standard caging. Curcumin administration increased Grp94 protein levels about twofold in muscles of ambulatory rats (P < 0.05) and antagonized its decrease in unloaded ones. Treatment countered loss of soleus mass and myofibre cross-sectional area by approximately 30% (P ≤ 0.02) and maintained a force-frequency relationship closer to ambulatory levels. Indexes of muscle protein and lipid oxidation, such as protein carbonylation, revealed by Oxyblot, and malondialdehyde, measured with HPLC, were significantly blunted in unloaded treated rats compared to untreated ones (P = 0.01). Mechanistic involvement of Grp94 was suggested by the disruption of curcumin-induced attenuation of myofibre atrophy after transfection with antisense grp94 cDNA and by the drug-positive effect on the maintenance of the subsarcolemmal localization of active neuronal nitric oxide synthase molecules, which were displaced to the sarcoplasm by unloading. The absence of additive effects after combined administration of a neuronal nitric oxide synthase inhibitor further supported curcumin interference with this pro-atrophic pathway. In conclusion, curcumin represents an effective and safe tool to upregulate Grp94 muscle levels and to maintain muscle function during unweighting.
CNR-Institute for Neuroscience, Padova section, Padova, Italy.
Maurizio
M
Vitadello
Department of Biomedical Sciences, University of Padova, Padova, Italy Interuniversity Institute of Myology, Italy.
Elena
E
Germinario
Department of Biomedical Sciences, University of Padova, Padova, Italy.
Barbara
B
Ravara
CNR-Institute for Neuroscience, Padova section, Padova, Italy.
Luciano Dalla
LD
Libera
Department of Biomedical Sciences, University of Padova, Padova, Italy Interuniversity Institute of Myology, Italy.
Daniela
D
Danieli-Betto
Department of Biomedical Sciences, University of Padova, Padova, Italy luisa.gorza@unipd.it.
Luisa
L
Gorza
D000818:Animals; D000975:Antioxidants / Q000494:pharmacology* / Q000627:therapeutic use; D003474:Curcumin / Q000494:pharmacology* / Q000627:therapeutic use; D005260:Female; D019417:Hindlimb Suspension / Q000502:physiology; D008562:Membrane Glycoproteins / Q000378:metabolism; D018482:Muscle, Skeletal / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology / Q000502:physiology; D009133:Muscular Atrophy / Q000188:drug therapy / Q000378:metabolism* / Q000503:physiopathology; D052248:Nitric Oxide Synthase Type I / Q000378:metabolism*; D017208:Rats, Wistar; D012508:Sarcolemma / Q000378:metabolism
D000975:Antioxidants; D008562:Membrane Glycoproteins; C053387:endoplasmin; D052248:Nitric Oxide Synthase Type I; D003474:Curcumin